Blueprint Medicines Corp. (BPMC)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 1 |
Ownership rank: | 684 |
% of all portfolios: | 0.004% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
47 |
$16,993,404 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
≡ |
Torray Funds |
0.28 |
Add 0.96% |
19,420 |
1,842,000 |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
07 Nov 2022 |
HAVILAND KATE |
CHIEF EXECUTIVE OFFICER |
03 Nov 2022 |
1,100 |
43.98 |
48,378 |
30 Jun 2022 |
DEMETRI GEORGE |
Director |
13 Jul 2021 |
10 |
82.66 |
827 |
07 Mar 2022 |
GOLDBERG MARK ALAN |
Director |
03 Mar 2022 |
5,000 |
59.98 |
299,900 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock